Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

E. Forcade · SciRah

Researcher profile · Semantic Scholar

E. Forcade

Share profile

E. Forcade — researcher profile on SciRah

h-index: 27
Works: 276
Citations: 2,609

Most-cited papers

Haploidentical stem cell donor choice for patients with acute myeloid leukemia: a study from the ALWP of the EBMT
Jaime Sanz, M. Labopin, D. Blaise, A. Raiola +20 more
2024Blood Advances30 citations Open access
Semantic Scholar
Long-term outcomes of patients with large B-cell lymphoma treated with axicabtagene ciloleucel and prophylactic corticosteroids
Olalekan O. Oluwole, E. Forcade, J. Munoz, S. de Guibert +22 more
2024Bone Marrow Transplantation30 citations Open access
Semantic Scholar
Human Leukocyte Antigen Mismatching and Survival in Contemporary Hematopoietic Cell Transplantation for Hematologic Malignancies
Esteban Arrieta-Bolaños, E. Bonneville, P. Crivello, M. Robin +22 more
2024Journal of Clinical Oncology26 citations Open access
Semantic Scholar
Efficacy and safety of belumosudil for treatment of cGVHD: multicenter retrospective analysis of the French cohort of the compassionate use program, on behalf of the French Society of Bone Marrow Transplantation and Cellular Therapy
D. Michonneau, F. Malard, Sophie Le Grand, Léonardo Magro +14 more
2025Bone Marrow Transplantation18 citations Open access
Semantic Scholar
Directionality of HLA-DP permissive mismatches improves risk prediction in HCT for acute leukemia and MDS.
Esteban Arrieta-Bolaños, L. V. D. van der Burg, T. Gedde-Dahl, M. Robin +16 more
2024Blood17 citations
Semantic Scholar
Harmonisation of quality control tests for academic production of CAR-T cells: a position paper from the WP-bioproduction of the UNITC consortium
Chrystel Marton, Béatrice Clémenceau, G. Dachy, Clemence Demerle +23 more
2025Bone Marrow Transplantation15 citations Open access
Semantic Scholar
Bone marrow graft versus peripheral blood graft in haploidentical hematopoietic stem cells transplantation: a retrospective analysis in1344 patients of SFGM-TC registry
C. Lacan, Jérôme Lambert, E. Forcade, M. Robin +35 more
2024Journal of Hematology & Oncology15 citations Open access
Semantic Scholar
Donor KIR genotype based outcome prediction after allogeneic stem cell transplantation: no land in sight
J. Schetelig, H. Baldauf, F. Heidenreich, J. Hoogenboom +25 more
2024Frontiers in Immunology15 citations Open access
Semantic Scholar
The landscape of immune monitoring in CAR-T cell therapy: A comprehensive review and survey study by the Cellular Therapy and Immunobiology Working Party of the EBMT.
S. Pagliuca, F. Malard, J. Mooyaart, M. Daskalakis +21 more
2025Blood reviews14 citations Open access
Semantic Scholar
Brexucabtagene autoleucel for BTKi-naive relapsed/refractory mantle cell lymphoma: primary analysis of ZUMA-2 cohort 3
T. van Meerten, M. J. Kersten, G. Iacoboni, Georg Hess +22 more
2025Blood13 citations Open access
Semantic Scholar
Involvement of the JAK‐STAT pathway in the molecular landscape of tyrosine kinase fusion‐negative hypereosinophilic syndromes: A nationwide CEREO study
Matthieu Groh, L. Fenwarth, M. Labro, A. Boudry +38 more
2024American journal of hematology/oncology12 citations Open access
Semantic Scholar
Five-Year Outcomes of Patients (Pts) with Relapsed/Refractory Mantle Cell Lymphoma (R/R MCL) Treated with Brexucabtagene Autoleucel (Brexu-cel) in ZUMA-2 Cohorts 1 and 2
Michael Wang, A. Goy, Javier L. Munoz, F. Locke +18 more
2024Blood12 citations
Semantic Scholar
Ruxolitinib Versus Best Available Therapy in Patients With Steroid-Refractory Acute Graft-Versus-Host Disease: Final Analysis From the Randomized Phase III REACH2 Trial
M. Mohty, Gérard Socié, J. Szer, D. Niederwieser +16 more
2025Journal of Clinical Oncology10 citations Open access
Semantic Scholar
Long‐term outcome after allogeneic stem cell transplantation for GATA2 deficiency: An analysis of 67 adults and children from France and Belgium
F. Sicre de Fontbrune, F. Chevillon, M. Fahd, K. Desseaux +17 more
2024British Journal of Haematology9 citations Open access
Semantic Scholar
Overall Survival After Allogeneic Transplantation in Advanced Cutaneous T-Cell Lymphomas (CUTALLO): A Propensity Score-Matched Controlled Prospective Study.
A. de Masson, M. Beylot-Barry, C. Ram-Wolff, J. Mear +46 more
2025Journal of Clinical Oncology8 citations Open access
Semantic Scholar
Lower relapse incidence with HAPLO versus MSD or MUD HCTs for AML patients with KMT2A rearrangement: a study from the Global Committee and the ALWP of the EBMT
Yi-Shan Ye, M. Labopin, Jia Chen, De-Pei Wu +17 more
2024Blood Cancer Journal8 citations Open access
Semantic Scholar
Treosulfan compared to busulfan in allogeneic haematopoietic stem cell transplantation for myelofibrosis: a registry-based study from the Chronic Malignancies Working Party of the EBMT
M. Robin, S. Iacobelli, L. Koster, J. Passweg +21 more
2024Bone Marrow Transplantation8 citations Open access
Semantic Scholar
Daratumumab for PRCA after HCT: study and practical considerations from the EBMT Transplant Complications Working Party
N. Gagelmann, M. D. de Witte, C. Peczynski, W. Boreland +26 more
2025Blood Cancer Journal7 citations Open access
Semantic Scholar
Identification of the conditions and minimum requirements necessary for the release of autologous fresh CAR T-cell products under hospital exemption: a position paper from the WP-bioproduction of the UNITC consortium
O. Boyer, Daniele Bensoussan, H. Bönig, C. Chabannon +20 more
2025Bone Marrow Transplantation7 citations
Semantic Scholar
Allogeneic stem cell transplantation in de novo core-binding factor acute myeloid leukemia in first complete remission: data from the EBMT
Rama Al Hamed, M. Labopin, De-Pei Wu, T. Gedde-Dahl +19 more
2024Bone Marrow Transplantation7 citations Open access
Semantic Scholar
Complex karyotype but not other cytogenetic abnormalities is associated with worse posttransplant survival of patients with nucleophosmin 1‐mutated acute myeloid leukemia: A study from the European Society for Blood and Marrow Transplantation Acute Leukemia Working Party
N. Moukalled, M. Labopin, J. Versluis, G. Socié +15 more
2024American journal of hematology/oncology7 citations Open access
Semantic Scholar
Haploidentical transplantation in primary refractory/relapsed secondary vs de novo AML: from the ALWP/EBMT
A. Nagler, M. Labopin, J. Tischer, A. Raiola +10 more
2024Blood Advances7 citations Open access
Semantic Scholar
The impact of ABO compatibility on allogeneic hematopoietic cell transplantation outcomes: a contemporary and comprehensive study from the transplant complications working party of the EBMT
Mustafa Güven, C. Peczynski, W. Boreland, D. Blaise +25 more
2025Bone Marrow Transplantation6 citations Open access
Semantic Scholar
Graft-versus-host-disease prophylaxis with ATG or PTCY in patients with lymphoproliferative disorders undergoing reduced intensity conditioning regimen HCT from one antigen mismatched unrelated donor
A. Paviglianiti, M. Ngoya, Marta Peña, A. Boumendil +14 more
2024Bone Marrow Transplantation6 citations Open access
Semantic Scholar
Severe ICANS after CAR T-cell therapy and assessment of prevention with levetiracetam for seizure prophylaxis following CAR T-cell for DLBCL & PMBCL in Europe: a survey on behalf of the Cellular Therapy & Immunobiology Working Party (CTIWP) of the EBMT
P. Angelillo, Ana Alarcon Tomas, E. Campodonico, U. Novak +26 more
2024Bone Marrow Transplantation6 citations
Semantic Scholar
PD-1 blockade and allogeneic hematopoietic stem cell transplantation in Hodgkin lymphoma, a matter of time: a national study on behalf of the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire
E. Kaphan, F. Bettega, Nicolas Vallet, N. Fégueux +24 more
2024Haematologica6 citations Open access
Semantic Scholar
Nilotinib efficacy and safety as salvage treatment following imatinib intolerance and/or inefficacy in steroid refractory chronic graft-versus-host-disease (SR-cGVHD): a prospective, multicenter, phase II study on behalf of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy
M. Srour, Tamim Alsuliman, J. Labreuche, C. Bulabois +10 more
2023Bone Marrow Transplantation6 citations Open access
Semantic Scholar
Non‐T‐Depleted Haploidentical Transplantation Compared to Allogeneic Transplantation From Matched Siblings or Unrelated Donors in Patients With Secondary AML in First Complete Remission: A Study From the ALWP/EBMT
A. Nagler, Sarah Kayser, Allain-Thibeault Ferhat, N. Kroger +17 more
2025American journal of hematology/oncology5 citations Open access
Semantic Scholar
Chronic Graft-versus-Host disease trends over 30 years - a study by the EBMT transplant complications working party
D. Pulanić, C. Peczynski, W. Boreland, C. Rautenberg +15 more
2025Bone Marrow Transplantation5 citations
Semantic Scholar
Efficacy and safety of Daratumumab for the treatment of ABO-incompatible pure red cell aplasia after allogenic HSCT: report from SFGM-TC
Thomas Longval, Anne-Claire Leprêtre, Aurélie Ravinet, Amandine Fayard +12 more
2024Bone Marrow Transplantation5 citations Open access
Semantic Scholar
Recursive Partitioning to Differentiate Acquired From Inherited Bone Marrow Failure Syndromes
E. Kaphan, A. Walter-Petrich, L. Larcher, Thierry Leblanc +13 more
2025American journal of hematology/oncology4 citations Open access
Semantic Scholar
Older matched sibling donor vs young haploidentical donor for older patients with acute myeloid leukemia
X. Poiré, M. Labopin, E. Polge, D. Blaise +15 more
2025Blood Advances4 citations Open access
Semantic Scholar
IDALLO study: A retrospective multicenter study of the SFGM‐TC evaluating the efficacy and safety of ivosidenib in relapsed IDH1‐mutated AML after allogeneic hematopoietic cell transplantation
A. Caillet, Marion Simonet-Boissard, E. Forcade, M. Robin +13 more
2024HemaSphere4 citations Open access
Semantic Scholar
Challenging the Adverse Label: Diverse Outcomes of ELN 2022 Adverse Cytogenetic Subgroups in Acute Myeloid Leukemia Patients Allografted in First Remission: From EBMT ALWP
A. Bazarbachi, J. Galimard, I. A. Dalle, G. Socié +16 more
2025American journal of hematology/oncology3 citations Open access
Semantic Scholar
Total-body irradiation-based versus chemotherapy alone as myeloablative conditioning regimen prior to hematopoietic allogeneic stem cell transplantation in adults with acute lymphoblastic leukemia: a multi-institutional study from the Francophone Society of Bone Marrow Transplantation and Cellular T
Yazid Belkacemi, K. Debbi, Nhu Hanh To, R. de Latour +23 more
2025International Journal of Radiation Oncology, Biology, Physics3 citations
Semantic Scholar
Comparison of Outcomes after UM171-Expanded Cord Blood and Six Conventional Donor Source Transplants: A Matched Analysis from the EBMT Registry.
S. Cohen, M. Labopin, N. Bambace, Imran Ahmad +18 more
2025Transplantation and Cellular Therapy3 citations Open access
Semantic Scholar
Dynamics of Oligoclonal Hematopoiesis in Severe Aplastic Anemia Patients Undergoing Immunosuppressive Treatment: Longitudinal Somatic Mutation Analysis from the EBMT Race Trial
D. Kaya, Riley Cook, S. Iacobelli, A. Kulasekararaj +21 more
2024Blood3 citations
Semantic Scholar
Allogeneic haematopoietic cell transplantation for therapy-related myeloid neoplasms arising following treatment for lymphoma: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT
M. Nabergoj, Diderik-Jan Eikema, L. Koster, U. Platzbecker +23 more
2024Bone Marrow Transplantation3 citations
Semantic Scholar
Choice of commercially available CAR-T cell products for r/r DLBCL & PMBCL in Europe: a survey on behalf of the cellular therapy & immunobiology working party (CTIWP) of the EBMT
U. Novak, J. Mooyaart, M. Daskalakis, C. Scheid +18 more
2024Bone Marrow Transplantation3 citations Open access
Semantic Scholar
Efficacy and Safety of Pegcetacoplan in PNH Patients with Extra-Vascular Hemolysis Under Anti-C5: The Real-Life Experience of the National French Reference Center
F. Sicre de Fontbrune, E. Forcade, L. Terriou, A. Garnier +6 more
2024Blood3 citations
Semantic Scholar
Trends in allogeneic transplantation for favorable risk acute myeloid leukemia in first remission: a longitudinal study of >15 years from the ALWP of the EBMT
A. Nagler, M. Labopin, U. Salmenniemi, De-Pei Wu +17 more
2024Bone Marrow Transplantation3 citations Open access
Semantic Scholar
Cord blood transplantation for AML: Comparable LFS in patients with de novo versus secondary AML in CR1, an ALWP/EBMT study
F. Baron, A. Nagler, J. Galimard, Jaime Sanz +20 more
2023British Journal of Haematology3 citations Open access
Semantic Scholar
Outcomes of patients over 70 years treated with brexu-cel for R/R mantle cell lymphoma: a study from the CTIWP of EBMT
Nicole Santoro, J. Mooyaart, U. Novak, R. Protheroe +19 more
2026Blood Advances2 citations Open access
Semantic Scholar
Better Outcome Following Younger Haploidentical Donor Versus Older Matched Unrelated Donor Transplant for Fit Patients With Acute Myeloid Leukemia Transplanted in First Remission: A Study From the Global Committee and the Acute Leukemia Working Party of the EBMT
Yi-Shan Ye, Allain Thibeault Ferhat Berland, M. Labopin, Jia Chen +18 more
2025American journal of hematology/oncology2 citations Open access
Semantic Scholar
Impact of fludarabine dose on outcome after allo-HSCT with reduced intensity conditioning for older patients with AML
G. Dachy, M. Labopin, G. Socié, C. Castilla-Llorente +16 more
2025Bone Marrow Transplantation2 citations
Semantic Scholar
HLA Mismatching and Transplant Outcome in the Ptcy Era: A Comprehensive Study By the EBMT Cellular Therapy and Immunobiology Working Party
Esteban Arrieta Bolaños, E. Bonneville, M. Robin, T. Gedde-Dahl +22 more
2024Transplantation and Cellular Therapy2 citations Open access
Semantic Scholar
Relapse Incidence Post Unrelated Allogeneic Stem Cell Transplantation with Post-Transplant Cyclophosphamide (PTCy) in Patients with Acute Myeloid Leukemia: A Study on Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
Arnon Nagler, M. Ngoya, J. Galimard, M. Labopin +17 more
2024Transplantation and Cellular Therapy2 citations Open access
Semantic Scholar
Primary Cancer Matters in Therapy-related Myeloid Neoplasm Patients Receiving Allogeneic Hematopoietic Cell Transplantation: A Study From the Chronic Malignancies Working Party of the EBMT
M. Robin, L. D. de Wreede, T. Schroeder, F. Stölzel +20 more
2023HemaSphere2 citations Open access
Semantic Scholar
Better outcomes with haploidentical than matched sibling donors for adult AML patients allo-transplanted in CR with detectable MRD: A study from the global committee and the ALWP of the EBMT.
Yi-Shan Ye, J. Galimard, M. Labopin, F. Ayuk +22 more
2025Blood1 citations
Semantic Scholar
CAR T-cell therapy versus autologous HSCT in patients with large B-cell lymphoma in complete remission: An analysis from the EBMT lymphoma working party
Rémy Duléry, Mathilde Fekom, C. Thieblemont, M. O'Reilly +21 more
2025Blood1 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

I. Yakoub-Agha×14
Invite
I. Yakoub-Agha — researcher profile on SciRah
A. Huynh×13
Invite
A. Huynh — researcher profile on SciRah
M. Labopin×12
Invite
M. Labopin — researcher profile on SciRah
D. Blaise×12
Invite
D. Blaise — researcher profile on SciRah

×12

Invite

M. Mohty — researcher profile on SciRah

Invite

F. Ciceri — researcher profile on SciRah

U. Salmenniemi×12

Invite

U. Salmenniemi — researcher profile on SciRah

Invite

N. Kroger — researcher profile on SciRah

A. Bazarbachi×10

Invite

A. Bazarbachi — researcher profile on SciRah

Invite

M. Robin — researcher profile on SciRah

T. Gedde-Dahl×10

Invite

T. Gedde-Dahl — researcher profile on SciRah

J. Maertens×10

Invite

J. Maertens — researcher profile on SciRah